Not to be used in foods, drugs, or medical diagnostics
Each vial is engineered for reproducible bench behaviour: tight purity tolerance, low aggregation under standard BAC reconstitution, and a CoA tied to the batch number printed on the label
This triple agonist design, developed by Eli Lilly under the research code LY3437943, represents a fundamentally different approach from semaglutide (which targets only GLP-1) or tirzepatide (which targets GLP-1 and GIP)
Some GLP-1 drugs have pediatric approval for certain conditions, but most have limited safety data in younger populations
The key difference is comprehensive care: tracking body composition, proper tapering, adequate hydration, appropriate exercise, and nutrition tailored to your needs
Eating more protein increases natural GLP-1 production. Thats true whether youre going through menopause or have an underlying health condition that makes you prone to weight gain